Buscar
DENTSPLY SIRONA Inc
XRAYAñadir a la lista de seguimiento
11.090USD
+0.480+4.52%
Cierre 07/01, 16:00（ET）Cotizaciones retrasadas 15 min
2.22BCap. mercado
PérdidaP/E TTM
Más Datos de DENTSPLY SIRONA Inc Compañía
DENTSPLY SIRONA Inc. is a manufacturer of professional dental products and technologies. It develops, manufactures, and markets a comprehensive solutions offering including dental and oral health products as well as other consumable medical devices. Its Connected Technology Solutions segment includes design, manufacture and sales of its dental technology and equipment products. Its Essential Dental Solutions segment includes the development, manufacture and sales of its value-added endodontic, restorative, and preventive consumable products and small equipment used by dental professionals for the treatment of patients. Its Orthodontic and Implant Solutions segment includes the design, manufacture, and sales of its various digital implant systems and dental implant products, digital dentures and dental professional-directed aligner solutions. Its Wellspect Healthcare segment includes the design, manufacture, and sales of its continence care solutions for urinary and bowel management.
Información de DENTSPLY SIRONA Inc
Símbolo de cotizaciónXRAY
Nombre de la empresaDENTSPLY SIRONA Inc
Fecha de salida a bolsaAug 12, 1987
Director ejecutivoScavilla (Daniel T)
Número de empleados14000
Tipo de seguridadOrdinary Share
Fin del año fiscalAug 12
Dirección13320 Ballantyne Corporate Place
CiudadCHARLOTTE
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal28277-3607
Teléfono18445463722
Sitio Webhttps://www.dentsplysirona.com/
Símbolo de cotizaciónXRAY
Fecha de salida a bolsaAug 12, 1987
Director ejecutivoScavilla (Daniel T)
Ejecutivos de DENTSPLY SIRONA Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Gregory T. (Greg) Lucier
Mr. Gregory T. (Greg) Lucier
Independent Chairman of the Board
Independent Chairman of the Board
106.94K
--
Mr. Jonathan Jay Mazelsky
Mr. Jonathan Jay Mazelsky
Independent Director
Independent Director
78.85K
+41.63%
Mr. Clyde R. Hosein
Mr. Clyde R. Hosein
Independent Director
Independent Director
70.57K
+41.55%
Ms. Janet S. Vergis
Ms. Janet S. Vergis
Independent Director
Independent Director
67.32K
+33.90%
Mr. Brian T. Gladden
Mr. Brian T. Gladden
Independent Director
Independent Director
61.85K
+53.04%
Mr. Willie A. Deese
Mr. Willie A. Deese
Independent Director
Independent Director
57.75K
+0.15%
Mr. Michael J. (Mike) Barber, M.D.
Mr. Michael J. (Mike) Barber, M.D.
Independent Director
Independent Director
55.94K
+67.92%
Mr. Daniel T. (Dan) Scavilla
Mr. Daniel T. (Dan) Scavilla
President, Chief Executive Officer, Interim Principal Financial Officer, Director
President, Chief Executive Officer, Interim Principal Financial Officer, Director
12.65K
-32.36%
Ms. Betsy D. Holden
Ms. Betsy D. Holden
Independent Director
Independent Director
--
--
Ms. Leslie F. Varon
Ms. Leslie F. Varon
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Gregory T. (Greg) Lucier
Mr. Gregory T. (Greg) Lucier
Independent Chairman of the Board
Independent Chairman of the Board
106.94K
--
Mr. Jonathan Jay Mazelsky
Mr. Jonathan Jay Mazelsky
Independent Director
Independent Director
78.85K
+41.63%
Mr. Clyde R. Hosein
Mr. Clyde R. Hosein
Independent Director
Independent Director
70.57K
+41.55%
Ms. Janet S. Vergis
Ms. Janet S. Vergis
Independent Director
Independent Director
67.32K
+33.90%
Mr. Brian T. Gladden
Mr. Brian T. Gladden
Independent Director
Independent Director
61.85K
+53.04%
Mr. Willie A. Deese
Mr. Willie A. Deese
Independent Director
Independent Director
57.75K
+0.15%
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de DENTSPLY SIRONA Inc?
Los cinco principales accionistas de DENTSPLY SIRONA Inc son: Mr. Gregory T. (Greg) Lucier
¿Cuál es la mayor fuente de ganancias de DENTSPLY SIRONA Inc?
El 2026Q4, el segmento empresarial Essential Dental Solutions generó la ganancia más alta para DENTSPLY SIRONA Inc, ascendiendo a 1.47B y representando el 39.92% de la ganancia total.